Exploring the Development of Novel Endpoints & Negotiating Endpoint Approval with Regulatory Bodies
Time: 11:30 am
day: Conference Day One
Details:
- Examining how endpoints are determined by considering starting points, planning, and use of biomarkers
- Discussing the iterative process that must be done to validate the endpoints
- Sharing advice on negotiations with regulatory bodies to facilitate more efficient conversations
